Condition (MeSH)
Obesity Hypoventilation Syndrome
ClinicalTrials.gov lists 72 trials for Obesity Hypoventilation Syndrome or a narrower condition beneath it. Fisher and Paykel Healthcare has the most among industry and government lead sponsors, with 5.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
72 of the 72 trials are tagged with Obesity Hypoventilation Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Obesity Hypoventilation Syndrome trials start? (20)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 3
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 7 |
| 2024 | 3 |
| 2023 | 4 |
| 2022 | 5 |
| 2021 | 3 |
| 2020 | 5 |
| 2019 | 6 |
| 2018 | 4 |
| 2017 | 1 |
Showing 10 of 20 earlier years.
No forecast is made for this condition: it averages 3.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Obesity Hypoventilation Syndrome trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 2 |
| Not applicable | 41 |
| Observational | 26 |
How many Obesity Hypoventilation Syndrome trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 4 |
| Recruiting | 2 |
| Completed | 37 |
| Suspended | 1 |
| Terminated | 9 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Obesity Hypoventilation Syndrome trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Fisher and Paykel Healthcare | 5 |
| ResMed | 4 |
| Philips Respironics | 2 |
| Air Liquide Santé International | 1 |
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Microbiological sampling (swab collection) | 1 |
| Acetazolamide Pill | 1 |
| Diet | 1 |
| Ketogenic diet | 1 |
| AD981 | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Obesity Hypoventilation Syndrome trials report? (3)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Chest Pain | 1 | 1 |
| Fournier's Gangrene | 1 | 1 |
| Multiple Falls | 1 | 1 |
Which publications cover Obesity Hypoventilation Syndrome? (79)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Adherence to long-term non-invasive positive airway pressure therapy. | Danish medical journal | 2024 | Yes |
| Cost-effectiveness of outpatient versus inpatient non-invasive ventilation setup in obesity hypoventilation syndrome: the OPIP trial. | Thorax | 2023 | Yes |
| Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine | 2022 | Yes |
| Severity stages of obesity-related breathing disorders - a cross-sectional cohort study. | Sleep medicine | 2022 | Yes |
| Respiratory Muscle Endurance in Obesity Hypoventilation Syndrome. | Respiratory care | 2022 | Yes |
Showing 5 of 79 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.